AuF Symposium 2026

"Targets & Theranostics in Uro-Oncology" – meet BIOTYPE at the AuF Symposium 2026!

Precision medicine depends on detecting the right molecular targets quickly and reliably. This is exactly what this year’s theme of the AuF Symposium – “From Natural Science to Precision Medicine: Targets and Theranostics in Urology” – is all about.

At the 17th DGU Symposium on Urological Research, BIOTYPE will present its molecular diagnostic portfolio for bladder cancer:

• Detection of FGFR3 Mutations and FGFR2/3 Gene Fusions with BIOTYPE’s FGFR Panel
• Gene expression analysis of therapy-relevant targets such as Nectin-4 with BIOTYPE’s TargetXpress Panel

Would you like to talk about bringing new targets into routine diagnostics? Arrange a meeting with Vanessa Grunwald and Alexander Hennig at the AuF Symposium 2026.